about
Neoadjuvant nab-paclitaxel in the treatment of breast cancerEvolving Evidence of the Efficacy and Safety of nab-Paclitaxel in the Treatment of Cancers with Squamous HistologiesThe role of taxanes in triple-negative breast cancer: literature reviewAlbumin-bound paclitaxel in solid tumors: clinical development and future directionsAn in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line.FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancerMetastatic pancreatic cancer: Is there a light at the end of the tunnel?Advances in chemotherapy for pancreatic cancerPhase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma.Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis.Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells.Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.Gene expression of peripheral blood cells reveals pathways downstream of glucocorticoid receptor antagonism and nab-paclitaxel treatment.State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesPancreatic cancer and its stroma: a conspiracy theoryNab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer.Co-opting biology to deliver drugsNewly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma.How lipidomics provides new insight into drug discovery.Change of SPARC expression after chemotherapy in gastric cancerCore-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical TranslationNab-paclitaxel-associated photosensitivity: report in a woman with non-small cell lung cancer and review of taxane-related photodermatoses.Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin.Controlled Drug Delivery: Historical perspective for the next generation.Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients.Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drugRedirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver MetastasesA retrospective analysis of safety and efficacy of weekly nab-paclitaxel as second-line chemotherapy in elderly patients with advanced squamous non-small-cell lung carcinoma.A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinomaSWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression.Drug Delivery Research: The Invention Cycle.Uptake carriers and oncology drug safety.Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids.Peritoneal cancer treatment.Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.Mass spectrometry in the pharmacokinetic studies of anticancer natural products.A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model.
P2860
Q26748822-7401F5E9-9968-493C-8722-7C02F9DBDAD9Q26766254-B6D388D1-B25F-4CA6-B5E5-56D9A3A67ECFQ26798356-20B2492B-3915-450B-9F35-DDCFF8BB38C5Q26798674-F2FED407-C256-4FC8-908E-32ADD351A6D8Q27336445-16EBECFB-8514-43BE-9BC5-6C3A589F698DQ28075540-599E3056-4FA8-4700-A03C-7682CF426A64Q28082919-910C751A-AF97-4A85-9854-F0A29494548CQ28085711-6FD65AEB-D1E7-4B34-ABDF-F30D66A51CD1Q33411962-2C8F5E79-C337-4913-93B6-3733CC37B5F4Q33440500-750865FE-521E-4FDC-B906-970003BB6C49Q33751197-1952B1D0-FBB8-4AF0-91FF-CD2E3D09A194Q33962553-B71CC00B-2747-42B1-B709-4A62306E52CCQ34005665-3EED47B2-6504-4A3B-960B-BFCF4AC42F33Q34045119-7CA9A1AF-5506-4C51-A288-E7F671C30283Q34093809-1A4E1C75-394A-44F6-B5F3-1B0F0B3BD10DQ34422252-B5BEB827-C509-426A-B9C4-E67398F86282Q34424045-7687844C-9919-4C4E-84D8-AEB1E987533BQ35051870-7DF39085-58F3-43EB-ADD4-C6BD729E8589Q35167171-10A3F45C-3F73-4F75-B921-190BB72CB28AQ35252935-1C24D624-F859-4A4A-972E-BFA18509F290Q35438759-EA49342E-2CC9-4E63-8F7D-F3637F74B507Q35717645-AD15B8D2-B153-4780-A024-6F12A934D305Q36010344-8B4FC8B0-D89B-4B6D-99D0-ED66BB4DA791Q36134678-297F6AFB-2DF6-4F99-85CC-661987334127Q36307613-ABAFEC92-BA2F-4BE5-8DB4-35C6E0D253BAQ36326026-E5C95213-B6DA-44ED-8B76-161715D88402Q36340055-CDC990E1-7B65-4FD8-9102-01D7BE2841E5Q36471409-9FAD8ED6-B53D-4BE4-B2E5-D0E98D10D233Q36617748-0BEB52DC-D0D3-402D-B9D5-86442DD86003Q36848514-322DA559-C70E-4D62-A1C7-C0AB37813F53Q37131869-D118DA88-7969-41E0-AE84-6CACEB63C341Q37583130-9A8255C5-4DAA-4011-BC9D-189BEFD54A6AQ37659183-005ACAF4-5787-454D-A928-950DCC9F5F69Q37663396-8F46CA5A-0F98-439C-8541-EAACC9D813E7Q37718422-ADFF3EED-5E6D-4CD6-BFE4-B8FCE1599B5FQ38195114-1CD70FA7-6DE3-49D2-BE91-9ECD577C21A6Q38247299-5941BA33-3738-47B1-AAE3-CAACCFD4D64DQ38568180-B5C40C19-24C9-49B4-9422-3EBEE62A0AC7Q38593792-C554C161-07B7-49F7-8DAD-0473A12AB0CAQ38776511-1D8AA1B0-4C96-48A8-BED4-246807908224
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
nab-Paclitaxel mechanisms of action and delivery.
@en
type
label
nab-Paclitaxel mechanisms of action and delivery.
@en
prefLabel
nab-Paclitaxel mechanisms of action and delivery.
@en
P1476
nab-Paclitaxel mechanisms of action and delivery.
@en
P2093
Denise A Yardley
P304
P356
10.1016/J.JCONREL.2013.05.041
P407
P577
2013-06-11T00:00:00Z